Health Law Vitals - A Healthcare Newsletter from Haynes and Boone, December 2018
by Stacy Brainin, Christopher Rogers, Nicole Somerville, Taryn McDonald, Jennifer Kreick, Phillip Kim, Neil Issar, Kayla Cristales
Published: December, 2018
Submission: February, 2019
Should States Embrace Telehealth Parity?
Parity in telehealth is the notion that health services provided via telehealth technology should be treated equally as health services provided face-to-face. This is consistent with coverage parity, which requires payors to provide the same level of insurance coverage for patient encounters and services, while payment parity (a.k.a. reimbursement parity) requires payors to pay or reimburse providers the same rates whether the encounter or service provided occurred in person or via telehealth.Read more
Differences and Similarities Between the Federal Anti-Kickback Statute and the 2018 Eliminating Kickbacks in Recovery Act
The Eliminating Kickbacks in Recovery Act of 2018 (EKRA) marks a significant shift in federal oversight of the healthcare industry, applying the general rule against paying remuneration related to referrals of patients for items or services regardless of payor. For a specific—but broad—subset of providers, paying any remuneration to induce referrals now carries significant potential criminal and civil liability under EKRA and the False Claims Act.Read more
District Court Overturns 60 Day Rule for Medicare Advantage Plans
UnitedHealthcare Insurance Co. recently secured a significant victory with potentially far-reaching consequences when the United States District Court for the District of Columbia vacated the 60-Day Overpayment Rule applicable to Medicare Advantage plans (the "Overpayment Rule"). The court's decision could potentially impact traditional Medicare providers as well since the language at issue in the case tracks the separate but similar 60-day overpayment rule applicable to traditional Medicare.Read more
Link to article
- The Danish Regions Propose to Establish a Treatment Council
- Federal Circuit Clarifies Limits of Safe Harbor Defense in Amgen v. Hospira
- New Kickback Law Targeting Opioid Treatment Facilities Could Affect Traditional Lab Arrangements
- Federal Circuit Clarifies Law of Obviousness-Type Double Patenting: Patent Term Extension and Patent Term Due to URAA Are Safe from Gilead v. Natco
WSG Member: Please login to add your comment.